Manufacturing giant Johnson & Johnson is facing allegations of product liability for its alleged concealment of the risk of developing ovarian cancer by using products containing toxic talcum powder. The case, Hogans, et al. v. Johnson & Johnson, is one of thousands of such claims pending against the company and the third in this multi-district litigation action to go to trial.
The two previous talc injury cases that went to trial resulted in verdicts of $72 million and $55 million, respectively. It’s estimated there are 1,200 lawsuits pending in Missouri and New Jersey, and the outcome of this third case could dictate whether the company moves to settle those pending cases (and for how much) or whether it continues to fight them.
The plaintiff in this action has been diagnosed with Stage Four ovarian cancer. She has reportedly used Johnson & Johnson’s talc powder products on her genitals for most of her adult life. She alleges the company was aware that talc applied in this region could travel to the ovaries and pose a risk of deadly cancer, and yet it chose to conceal this information from the public.